+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Amitiza"

Irritable Bowel Syndrome Treatment Market Size, Share & Analysis Report by Type (IBS-C, IBS-D), Product (Xifaxan, Linzess/Constella, Viberzi, Amitiza), Distribution Channel, Region, and Segment Forecasts, 2025-2030 - Product Thumbnail Image

Irritable Bowel Syndrome Treatment Market Size, Share & Analysis Report by Type (IBS-C, IBS-D), Product (Xifaxan, Linzess/Constella, Viberzi, Amitiza), Distribution Channel, Region, and Segment Forecasts, 2025-2030

  • Report
  • October 2024
  • 100 Pages
  • Global
From
Irritable Bowel Syndrome (IBS) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Irritable Bowel Syndrome (IBS) Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 269 Pages
  • Global
From
Opioid-Induced Constipation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Opioid-Induced Constipation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 136 Pages
  • Global
From
Chronic Constipation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Chronic Constipation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 132 Pages
  • Global
From
Chronic Idiopathic Constipation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Chronic Idiopathic Constipation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 134 Pages
  • Global
From
Irritable Bowel Syndrome Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031 - Product Thumbnail Image

Irritable Bowel Syndrome Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • Report
  • December 2023
  • 116 Pages
  • Global
From
Irritable Bowel Syndrome Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Irritable Bowel Syndrome Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Amitiza - API Insight, 2022 - Product Thumbnail Image

Amitiza - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Amitiza is a prescription medication used to treat chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). It is a chloride channel activator that works by increasing fluid secretion in the intestines, which helps to soften stools and increase bowel movements. It is available in 8 mcg and 24 mcg capsules. Amitiza is the only FDA-approved medication for CIC and IBS-C that works by increasing fluid secretion in the intestines. The Amitiza market is a subset of the larger gastrointestinal drugs market. It is composed of medications used to treat a variety of gastrointestinal conditions, including CIC and IBS-C. These medications are typically prescribed by gastroenterologists and other healthcare professionals. Some companies in the Amitiza market include Allergan, Ironwood Pharmaceuticals, and Takeda Pharmaceuticals. Show Less Read more